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OBJECTIVES We sought to analyze the histologic findings of 30 patients with a diagnosis of arrhythmo-
genic right ventricular dysplasia (ARVD) based on established clinical and instrumental
criteria, who did not have a family history of ARVD.
BACKGROUND The diagnostic role of endomyocardial biopsy (EMB) in patients with a clinical profile of
ARVD is still debated.
METHODS Thirty patients (19 male, 11 female, mean age 27  10 years) with left bundle branch block
morphology ventricular tachyarrhythmias and echocardiographic, angiographic, and magnetic
resonance imaging (MRI) findings diagnostic of ARVD were studied. All patients, besides
diagnostic, noninvasive, and invasive cardiac studies, underwent EMB in the apex, anterior
free wall, inferior wall of the right ventricle (RV) and in the septal-apical region of the left
ventricle.
RESULTS Diagnostic histologic features of ARVD were found only in 9 (30%) patients and a
myocarditis, according to the Dallas criteria, in the remaining 21 (70%) patients. Morpho-
metric evaluation of RV samples showed significant differences in fatty tissue and myocyte
percent area between ARVD and myocarditis (p  0.001). Conversely, no difference was
found between the two groups in arrhythmic patterns and structural and functional
echocardiographic, angiographic, and MRI RV alterations. Magnetic resonance imaging
showed hyperintense signals in 67% of ARVD and in 62% of myocarditis group (p  NS).
During follow-up (mean, 23  14 months), all patients with myocarditis remained stable on
antiarrhythmic therapy while five patients with ARVD required implantation of an implant-
able cardioverter defibrillator.
CONCLUSIONS A myocarditis involving the RV can mimic ARVD. An EMB appears the most reliable
diagnostic technique, with significant prognostic and therapeutic implications. (J Am Coll
Cardiol 2004;43:2305–13) © 2004 by the American College of Cardiology Foundationt
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5he occurrence of ventricular tachyarrhythmias with left
undle branch block morphology, particularly in the pres-
nce of echocardiographic, angiographic, and magnetic
esonance imaging (MRI) abnormalities confined to the
ight ventricle (RV), suggests a diagnosis of arrhythmogenic
ight ventricular dysplasia (ARVD) (1,2).
Standardized diagnostic criteria for this disease have been
efined (3), but their value in distinguishing sporadic cases
f ARVD from other arrhythmogenic cardiac diseases,
nvolving selectively the RV, is still unclear.
We report the histologic findings of biventricular biopsies
erformed in a series of 30 patients in whom the clinical
iagnosis of sporadic ARVD was made on accepted stan-
ard clinical and instrumental criteria.
ETHODS
atient selection and clinical studies. Among 78 consec-
tive patients (43 male, 35 female, mean age 38  17 years)
ith ventricular tachyarrhythmias, normal left ventricular
LV) global function, and normal coronary arteries hospi-
From the *Cardio-Thoracic and Vascular Department, San Raffaele Hospital,
ilan, Italy; and the †Cardiology Department, Catholic University, Rome, Italy.
artially supported by the grant “Sudden Death in Young People” from the Italian
inistry of Health, Italy.
Manuscript received June 13, 2003; revised manuscript received November 30,R003, accepted December 2, 2003.alized at our institution from 1998 to 2001, 30 (19 male, 11
emale, mean age 27 10 years) had tachyarrhythmias with
eft bundle branch block morphology associated with RV
orphologic and functional alterations. All patients were
ubmitted to noninvasive cardiac studies including resting
lectrocardiogram (ECG), signal-averaged ECG, Holter
onitoring, ECG stress test, two-dimensional Doppler
chocardiography, and cardiac MRI by ECG-triggered
ultislice spin-echo sequence and cine imaging with intra-
enously administered gadolinium.
To investigate possible occurrence of familial cardiomy-
pathies, ECG and echocardiographic studies were also
xtended to first-degree family members. Invasive studies
ere performed in all patients after informed consent and
pproval by the ethical committee of our institution. These
tudies included: electrophysiologic study according to the
merican College of Cardiology/American Heart Associa-
ion guidelines (class I indication), cardiac catheterization,
oronary angiography, right biplane ventriculography (30°
ight anterior oblique and 60° left anterior oblique), left
entriculography, and biventricular endomyocardial biopsy
EMB).
Biopsies were performed by a Bipal (Cordis, Miami,
lorida) bioptome, approached by a 7F (501-613 and
01-613A) long sheet both in the septal-apical region of the
V and in specific areas with wall motion abnormalities
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Histology in RV Cardiomyopathy June 16, 2004:2305–13i.e., apex, anterior free wall, inferior wall) (four to five
amples per patient) and in the septal-apical region of the
V (two to three specimens per patient). The regions
andidate for a biopsy were identified on an X-ray view
sing flashing of contrast medium. The tissue specimens
ere fixed in 10% buffered formalin and embedded in
araffin wax for histologic studies or snap frozen in OCT
ompound with isopentane cooled in liquid nitrogen and
tored at 80°C for molecular biology studies.
istologic studies. Six to eight endomyocardial samples (2
o 3 mm in depth, 3 to 4 mm in length) obtained from each
atient were processed for histologic and immunohisto-
hemical studies. For histology, multiple 5-m thick sec-
ions were cut and stained with hematoxylin-eosin, Miller’s
lastic Van Gieson, Masson’s trichrome, and examined by
ight microscopy. The Dallas criteria (4) were followed for
istologic diagnosis of myocarditis. Immunohistochemistry
or the characterization of inflammatory infiltrate was car-
ied out by using the following antibodies: CD45 (Dako
Carpinteria, California] 1:20), CD43 (Dako 1:40),
D45RO (Dako 1:100), CD20 (Dako 1:100), CD68
Dako 1:50), CD3 (Dako 1:50), CD4 (Novocastra [New
astle, United Kingdom] 1:50), CD8 (Dako 1:100), as
lready described (5). These antibodies recognize cluster of
ifferentiation molecules specific for different classes of
ymphocytes. Briefly, after deparaffination, the sections were
ncubated with the monoclonal antibody for 1 h at room
emperature and were then incubated with biotinylated
ntimouse immunoglobulins (Dako EnVision Peroxidase
ouse) for 30 min. Enzyme activity was detected with
iaminobenzidine (0.5 mg/ml) with 0.05% NiCl in 50
mol/l Tris buffer, pH 7.5, and sections were counter-
tained with Mayer’s hematoxylin.
To quantify the inflammatory infiltrates, CD45 positive
eukocytes and T-lymphocytes (CD3) were counted per
igh-power field (HPF) (400-fold magnification) in all
vailable fields, and the mean number was calculated, as
reviously described (6). More than 2.0 CD3-positive
ymphocytes per HPF (7 per mm2) were considered as
bnormal (6). The presence of an inflammatory infiltrate of
minimum of 14 infiltrating leukocytes/mm2 was consid-
red diagnostic for myocarditis (7).
Abbreviations and Acronyms
ARVD  arrhythmogenic right ventricular dysplasia
EMB  endomyocardial biopsy
HPF  high-power field
ICD  implantable cardioverter defibrillator
LV  left ventricle/ventricular
MRI  magnetic resonance imaging
nsVT  nonsustained ventricular tachycardia
PVB  premature ventricular beats
RV  right ventricle/ventricular
sVT  sustained ventricular tachycardiaFor morphometric analysis, RV histologic sections were txamined at 400 magnification with a reticule containing
2 sampling points (105844, Wild Heerbrugg Instruments,
als, Switzerland) (8). This reticule was used to determine
he percent area occupied by myocytes, fibrous tissue,
dipose tissue, and other components (vascular spaces,
nterstitial cells). Control RV biopsies (two to three per
atient) for quantitative evaluation of inflammatory infil-
rates and for morphometry were obtained from 15 age-
atched patients (26 12 years) at the time of a surgery for
trial septal defect repair. These control surgical endomyo-
ardial biopsies were collected in the setting of a pathologic
tudy approved by our ethical committee.
Because of the young age of the patients, a percentage of
atty tissue 3.5% was considered diagnostic of ARVD (9).
n fact, an increased amount of fatty tissue has been shown
n the heart of elderly (10) compared with the heart of
outh, where the adipose tissue is virtually absent (11).
olecular biology studies. Two frozen myocardial speci-
ens per patient were used to assess the presence of
ardiotropic viruses (adenovirus, enterovirus, cytomegalovi-
us, parvovirus B19, influenza A and B viruses, herpes
implex viruses, Epstein Barr virus, hepatitis C virus); PCR
nd RT-PCR analysis was performed as previously de-
cribed (5). Frozen endomyocardial samples from five age-
atched patients with chronic stable angina, no systemic
nfection, no history of myocarditis, and no histologic
vidence of cardiac inflammation were used as controls. In
our cases, the biopsies were surgical samples taken at the
ime of bypass surgery: two patients (25 and 29 years) were
ffected by familiar hypercholesterolemia and had multiple
oronary stenosis, two patients (43 and 39 years) were
ffected by a coronary stenosis involving only the left
nterior descending artery. The other control biopsies were
ndomyocardial specimens from a patient (33 years) affected
linically by chronic stable angina in absence of coronary
rtery stenosis (syndrome X). The biopsies were performed
oth in the RV and in the LV and were obtained from
ifferent regions (two to three samples per each patient).
he indication for this procedure was to study the in-
ramyocardial small vessels in a research project approved by
ur ethical committee.
reatment and follow-up. Patients with frequent and
omplex premature ventricular beats (PVB) and with non-
ustained ventricular tachycardia (nsVT) were treated with
otalol or beta-blockers.
Patients with sustained ventricular tachycardia (sVT)
ere treated according to the results of electrophysiologic
erial drug testing. An implantable cardioverter defibrillator
ICD) was implanted in inducible or spontaneous ventric-
lar tachycardia resistant to drug therapy (presence of sVT
n spite of a combined therapy with amiodarone and
eta-blockers) and in patients who had cardiac arrest.
All patients were followed at four-week intervals. The
ean duration of follow-up was 23  14 months. At each
isit, they underwent physical examination, basal ECG,
wo-dimensional echocardiogram, and Holter monitoring.
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June 16, 2004:2305–13 Histology in RV Cardiomyopathyhe progression of the disease was evaluated on the basis of
worsening in RV structural and functional abnormalities
ith an eventual involvement of the LV by the pathologic
rocess and on the basis of the increased electrical instability
espite the medical treatment.
tatistical analysis. All values are expressed as mean 
D. A value of p  0.05 was considered significant.
ignificance between two values was determined by Student
test for unpaired data and by chi- square test. Comparison
etween groups was performed by the analysis of variance,
ith the Bonferroni t test correction, and all the p values
ere Bonferroni-corrected. A total of three comparisons
ere included in the correction.
igure 1. 12-lead electrocardiogram from a 27-year-old man with palpitat
orphology.
igure 2. 12-lead electrocardiogram from a 29-year-old woman presentin
ranch block pattern.ESULTS
linical studies. All 30 patients were admitted because of
he presence of ventricular arrhythmias with left bundle
ranch block morphology (Figs. 1 and 2), in absence of
amily history of ARVD. In addition, ECG and echocar-
iographic screening of first-degree family members was
egative.
Two (6.7%) patients were resuscitated from a cardiac
rrest due to ventricular fibrillation, 10 patients (33%)
resented episodes of sVT, 10 patients (33%) nsVT, and 8
27%) frequent ventricular ectopic beats (1,000/24 h on
olter monitoring). None had a family history of premature
showing a sustained ventricular tachycardia with left bundle branch block
th syncope, showing a sustained ventricular tachycardia with left bundleions,g wi
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Histology in RV Cardiomyopathy June 16, 2004:2305–13udden death or cardiomyopathy. Among the 30 patients,
1 (70%) showed depolarization/conduction abnormalities,
ncluding the presence of epsilon waves (2 patients) or
ocalized prolongation of the QRS complex in right precor-
ial leads (QRS110 ms) (13 patients) and/or the presence
f late potentials at signal-averaged ECG (11 patients).
nverted T waves on right precordial leads (V1 to V3) were
resent in eight (27%) patients.
All 30 patients showed global and/or regional dysfunction
nd structural alterations of the RV detected by echocardi-
graphy, angiography, and MRI (Figs. 3 and 4). In partic-
lar, global RV dilation and dysfunction were detected in 23
atients (77%), being of severe degree in 6 patients (echo-
ardiographic end-diastolic diameter  36  5 mm; ejec-
ion fraction  31  4%) and mild in the remaining 17
igure 3. Right ventricular angiography (20° right anterior oblique projec-
ion) from patient of Figure 1, showing multiple small aneurysms of the
nferior wall.
igure 4. Right ventricular angiography (30˚ right anterior oblique view)
rom patient of Figure 2, showing small localized aneurysms of the inferiorpnd posterior wall.atients (end-diastolic diameter  29  6; ejection fraction
45  7%). Segmental RV dilation with localized areas of
ypokinesia were present in seven patients (23%), of severe
egree in two, and mild in five. Left ventricular dimensions
nd global function were normal in all cases. Localized wall
otion abnormalities of the LV were present in three cases
10%).
Single or multiple localized aneurysms were detected in
9 patients (63%) by angiography and MRI and were
ocated in the inferior and inferobasal RV wall, at the apex
nd in the anterior RV wall.
At MRI, focal or diffuse intramyocardial areas of high-
ignal intensity in T1-weighted images, considered sugges-
ive of fatty tissue infiltration, were detected in 19 patients
63%). In particular, MRI showed hyperintense signals in
7% of ARVD and in 62% of the myocarditis group. The
iffuse or focal hyperintense signal areas were localized in
he apex and in the subtricuspid walls of the RV, and/or in
he pulmonary infundibulum (triangle of dysplasia).
Each patient received a diagnosis of ARVD on the basis
f two major criteria (12 patients, 40%) and of one major
lus at least two minor criteria (18 patients, 60%). Because
f the lack of specificity of the interpretation of MRI studies
n patients with suspected ARVD, as recently shown by
luemke et al. (12), the data from the MRI studies were not
sed for any of the diagnostic criteria.
istologic findings. The diagnosis of ARVD was con-
rmed by histologic findings in nine patients (30%).
onversely, focal inflammatory infiltrates with necrosis of
he adjacent myocytes, meeting the Dallas criteria for
yocarditis, associated with various amounts of intersti-
ial and replacement fibrosis, were present in all speci-
ens taken from the RV in the other 21 (70%) (Figs. 5
nd 6). Immunohistochemical staining confirmed the
resence of myocarditis. Morphometric analysis (Fig. 7)
howed a reduction in percent area of myocytes in ARVD
igure 5. Right ventricular endomyocardial biopsy from patient of Figures
and 3, showing a severe fibrofatty infiltration of the myocardium,
uggesting an arrhythmogenic right ventricular dysplasia (hematoxylin
osin 100).atients compared with myocarditis (44  9.2% and 68.2
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June 16, 2004:2305–13 Histology in RV Cardiomyopathy9.8%, respectively, p  0.001) with an increase in
dipose tissue (24  7.8% vs. 0.3  0.6%, p  0.001) and
omparable values of fibrosis (26  11.1% vs. 20  7.8%,
 NS). The morphometric analysis was a mean of the
valuation of all the specimens drawn from different sites
f the RV. There was a difference in the percentage of fat
mong the different specimens, having the biopsies from
he areas with more prominent structural abnormalities a
ore evident fatty replacement of the myocardium.
owever, the range of values was from 8% to 45%,
howing also in the specimens drawn from the interven-
ricular septum a percentage of adipose tissue diagnostic
or ARVD (Table 1). Control values for these parameters
ere 88.9  3.5% for myocytes (p  0.001 vs. ARVD, p
0.001 vs. myocarditis), 4.9  2.5% for fibrous tissue (p
0.001 vs. ARVD, p  0.001 vs. myocarditis), and 0.33
0.8 % for adipose tissue (p  0.001 vs. ARVD, p  NS
igure 6. Endomyocardial biopsy from the right ventricle from patients of
igures 2 and 4, showing an active lymphocytic myocarditis (arrows) (HE
50) with areas of interstitial and replacement fibrosis (F).
igure 7. Percentage of myocytes (Myo), adipose tissue (Adi), fibrosis
Fibr), and interstitium (Int) (other interstitial structures not including
dipose and fibrous tissue) in the myocardium of controls, myocarditis, and
rrhythmogenic right ventricular dysplasia (ARVD). Results are mean 
D. *p  0.001 ARVD vs. controls; †p  0.001 ARVD vs. myocarditis;tp  0.05 myocarditis vs. controls; §p  0.05 myocarditis vs. ARVD.s. myocarditis). Patchy inflammatory infiltrates were
resent in the RV of four patients with ARVD (44%).
he total number of CD45-positive cells and CD3-
ositive lymphocytes revealed abnormal values in all the
V biopsies from patients with myocarditis (CD45  8.2
2.7 per HPF, CD3  3.8  1.06 per HPF) and in the
V of the four patients with ARVD (CD45  5.6  1.3;
.15  0.45 per HPF). Control values for these param-
ters were: CD45  1.12  0.5 per HPF, CD3  0.5 
.3 per HPF. The quantification of the inflammatory
nfiltrates showed a difference between specimens drawn
rom areas with normal contractility and areas with wall
otion abnormalities, both in ARVD and in myocarditis
atients (Table 1).
The LV samples of all patients with ARVD were normal.
onversely, in 10 patients (48%) with RV myocarditis, an
V focal inflammation was detected. Among these 10
atients, 3 had localized LV wall motion abnormalities.
No complications related to EMB occurred in our pa-
ients, and no mesothelial cells, suggesting myocardial
erforation, were observed in any of the specimens.
Comparing the ECG-arrhythmic and morphofunctional
riteria of diagnosis in the two groups of patients, no
tatistically significant difference was detected for any of
hese parameters, as shown in Table 2.
olecular biology studies. In all patients, the presence of
ufficient target nucleic acid was confirmed by amplification of
eta-globin for deoxyribonucleic acid and 3GPDH for ribo-
ucleic acid. No viral genomes were detected in the myocar-
ium of patients with ARVD. Four of the 21 patients with
yocarditis (19%) were positive for myocardial viruses, includ-
ng enterovirus (2 patients) and adenovirus (2 patients). None
f the five controls was positive for any virus. Sequencing
nalysis of the PCR amplimers showed a high homology with
oxsackie virus B3 and adenovirus 2 and 5.
reatment and follow-up. Treatment and follow-up of 30
atients with clinical profile of ARVD are reported in
able 3.
Patients with frequent and complex PVB and with nsVT
ere treated with sotalol 240 mg (15 patients) or metoprolol
00 mg (3 patients). Patients with sVT were treated with
otalol 240 mg (seven patients) and amiodarone 400 mg
three patients). Two patients resuscitated from cardiac
rrest at the time of admission (one with ARVD and one
ith myocarditis) received an ICD.
At a mean follow-up of 23  14 months in patients
ith myocarditis, arrhythmias were controlled by antiar-
hythmic drugs, and no detectable disease progression
as observed. In particular, no localized or diffuse in-
rease in the RV dimension and no segmental or global
eduction of RV function from the baseline echocardio-
raphic measurement was detected. Conversely, life-
hreatening arrhythmias not controlled by antiarrhythmic
rug therapy, consisting of a combination of amiodarone
nd metoprolol, required ICD implantation in five pa-
ients with ARVD. In these patients, the arrhythmias
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Histology in RV Cardiomyopathy June 16, 2004:2305–13onsisted of frequent episodes of sVT symptomatic for
alpitation in three cases and for syncope in two. In three
f these five patients, a morphologic progression of the
isease was detected, consisting of an increase in RV
lobal dimension in one patient (end-diastolic diameter
rom 29 to 33 mm) with reduction of RV function
ejection fraction from 40% to 32%) and in the appear-
nce of a previously absent localized area of RV hypoki-
esia in the remaining two patients, one of them associ-
ted with LV apical hypokinesia. In the remaining cases
f ARVD, no disease progression was detected.
ISCUSSION
rrhythmias originating from the RV myocardium can be
aused by several cardiac disorders (13). In order to distin-
uish ARVD from other cardiac pathologies, the diagnostic
riteria established in 1994 included the demonstration of
bnormal fibrofatty replacement of the RV myocardium on
MB samples (3). However, the role of EMB is still
Table 1. Morphometric Data and Quantificati
With ARVD and Myocarditis in Normokineti
Biopsy Sites
Myocytes
% Area
N-A
Adipose Tissu
% Area
N-A
ARVD patients
1 44%-33% 23%-31%
2 52%-29% 26%-45%
3 52%-35% 18%-25%
4 55%-33% 19%-33%
5 60%-41% 8%-22%
6 46%-30% 19%-39%
7 58%-34% 15%-22%
8 59%-35% 21%-32%
9 63%-33% 10%-25%
Myocarditis patients
1 80%-78% 0%-0%
2 69%-51% 0.5%-1%
3 82%-55% 0.5%-0%
4 70%-57% 0%-0%
5 80%-50% 1.5%-0%
6 71%-59% 0%-0%
7 75%-59% 2%-0.5%
8 73%-60% 0%-0%
9 74%-60% 0%-0%
10 74%-60% 0%-0%
11 75%-60% 0%-1.5%
12 76%-63% 0%-1%
13 76%-63% 0%-0%
14 78%-59% 0%-0%
15 79%-64% 0%-0.5%
16 83%-65% 0%-0%
17 81%-65% 0%-0%
18 80%-65% 0%-2%
19 77%-66% 0%-0%
20 70%-63% 0%-0%
21 94%-67% 0%-0%
A  abnormal wall motion (ipo/dyskinetic) areas; ARVD 
field (400-fold magnification); Inf  infiltrates; N  normouestioned (14,15) because: 1) the low sensitivity of septal Tiopsies, as the septal involvement is uncommon; 2) the risk
f perforation of the RV free wall during the procedure; and
) the segmental distribution of the RV alteration particu-
arly at the early stage of the disease.
In our study we tried to overcome sampling limitation
erforming multiple biopsies even on RV free wall and
pproaching particularly those areas with wall motion ab-
ormalities.
In addition, EMBs were 2 to 3 mm in depth, represent-
ng RV thickness to a large extent and making it unlikely
hat ARVD lesions would be missed.
In our study, histology was diagnostic for ARVD in nine
atients (30%), being the typical findings more evident in
he samples from the regions close to the structural and
unctional RV anomalies.
Conversely, an RV myocarditis was detected in 70% of
ases in the absence of fatty replacement of the RV
yocardium consisting of ARVD, even in the biopsies
rawn from the areas with documented RV abnormalities.
the Inflammatory Infiltrates of Patients
Ipo-Dyskinetic Right Ventricular
Fibrous Tissue
% Area
N-A
Interstitium
% Area
N-A
Inflammatory
Inf CD3
Cells/HPF
N-A
28%-34% 5%-2% 0-0
12%-15% 10%-11% 0-3.2
22%-35% 8%-5% 0-0
18%-32% 8%-2% 0-2
16%-33% 16%-4% 0-2.5
21%-31% 14%-1% 0-0
23%-41% 4%-3% 0-0
12%-32% 8%-1% 0-2
20%-40% 7%-2% 0-0
10%-18% 10%-4% 3-6.2
16%-30% 14.5%-18% 3.5-5.5
10%-29% 7.5%-16% 2-4.5
20%-28% 10%-15% 2.5-5
10%-34% 8.5%-16% 2-5.3
12%-22% 17%-19% 3.6-5.1
15%-30% 8%-10.5% 3-6.2
13%-24% 14%-16% 3.2-5.2
14%-23% 12%-17% 3.5-7
15%-24% 11%-16% 2.6-6
15%-25% 10%-13.5% 2.1-4.1
16%-25% 8%-11% 2.6-4.8
16%-28% 8%-9% 2-3.5
17%-29% 5%-12% 2-5
18%-30% 3%-5.5% 2.2-4.5
11%-28% 6%-7% 2.5-6
10%-11% 9%-14% 2-3.5
12%-31% 8%-2% 3-5
19%-21% 4%-13% 3.3-8
20%-30% 10%-7% 2-6
4%-20% 2%-13% 2.5-6.5
thmogenic right ventricular dysplasia; HPF  high-power
areas; pts  patients.on of
c and
e
arrhyhis group of patients was affected by a prevalent right-
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June 16, 2004:2305–13 Histology in RV Cardiomyopathyided myocarditis simulating the clinico-instrumental char-
cteristics of an ARVD.
In a study by Witcher et al. (16), findings supporting the
iagnosis of RV dysplasia, which were defined as an
bnormal fibrolipomatous or adipose tissue infiltration ex-
eeding an area of 25% in one or more biopsy specimens,
ere present in 31 of 47 patients (66%). Nonspecific
ndings were found in 3 patients (6%), and EMB was
ormal in the remaining 13 patients (28%). There was no
vidence of an acute myocarditis or storage disease in any
atient. These results are at variance with the findings
etected in the present study. No major complications, as
ardiac perforation, occurred in our experience despite an
xtensive biventricular study.
Thus, in sporadic cases of ARVD, the histologic study
eems the most appropriate, and even safe, approach to
each a correct diagnosis.
ccepted standard clinical and instrumental criteria for
RVD. Echocardiography, angiography, and MRI are the
ost commonly used techniques for the diagnosis of
Table 2. Electrocardiographic-Arrhythmic and
ARVD Compared With Patients With Myoca
Mean age (yrs)
Gender (M, F) 9
Ventricular fibrillation
Sustained ventricular tachycardia
Nonsustained ventricular tachycardia
Premature ventricular beats
Depolarization/conduction abnormalities
Repolarization abnormalities
Right ventricular dilation
Global
Severe/mild 4
Segmental
Severe/mild
Right ventricular hypokinesia
Global
Severe/mild 4
Segmental
Severe/mild
Right ventricular aneurysms
*p  0.05 was considered significant.
ARVD  arrhythmogenic right ventricular dysplasia.
able 3. Arrhythmic Profile, Histology, Treatment, and Follow-U
rrhythmias
Number of
Patients Histology Trea
F 2 ARVD  1 (11%);
M  1 (5%)
ICD  1 AR
VT 10
ARVD  3 (33%);
M  7 (78%)
Sotalol  2 A
Amiodarone 
sVT 10
ARVD  3 (33%);
M  7 (78%)
Sotalol  2 A
Metoprolol 
VB 8
ARVD  2 (22%);
M  6 (29%)
Sotalol  2 A
Metoprolol 
RVD  arrhythmogenic right ventricular dysplasia; ICD  implantable cardiovert
ustained; U  unmodified; VF  ventricular fibrillation; VT  ventricular tachycardia.RVD. In particular, RV angiography is considered a
iagnostic reference standard. Localized areas of akinesia or
yskinesia in the apex, inferior and anterior wall, and global
r segmental RV dilation and systolic dysfunction (17) are
onsidered diagnostic of ARVD. However, in our series,
uch angiographic abnormalities were detected with a sim-
lar prevalence in both ARVD and myocarditis. In particu-
ar, RV aneurysms in the so-called “triangle of dysplasia”
18), considered to be pathognomonic of ARVD, were
resent also in 62% of patients with myocarditis. This
nding is consistent with the reported occurrence of inflam-
atory ventricular aneurysms, localized in the RV or in the
V, both in experimental models of myocarditis and in
umans (5–19).
More recently, cardiac MRI has been proposed as the
ost accurate noninvasive diagnostic technique for ARVD
20). In our series, MRI did not differentiate patients with
RVD from patients with myocarditis. In particular, the
etection of the hyperintense signal in T1-weighted images
as not diagnostic of ARVD, possibly because the hyper-
phofunctional Parameters of Patients With
carditis
 21)
ARVD
(n  9) *p
 10.8 29  7 NS
), 12 (57%) 5 (55%), 4 (44%) NS
(5%) 1 (11%) NS
(33%) 3 (33%) NS
(33%) 3 (33%) NS
(29%) 2 (22%) NS
(52%) 3 (33%) NS
(24%) 3 (33%) NS
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(62%) 6 (67%) NS
30 Patients With Clinical Profile of ARVD
t at Discharge Follow-Up
11%), 1 M (5%) U  1 ARVD (11%), 1 M (5%)
(22%), 5 M (24%) U  7 M (33%)
RVD (11%), 2 M (9%) ICD  3 ARVD (33%)
(22%), 6 M (29%) U  1 ARVD (sotalol) (11%), 7 M (33%)
VD (11%), 1 M (5%) ICD  2 ARVD (22%)
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Histology in RV Cardiomyopathy June 16, 2004:2305–13ntense signals are not specifically related to adipose tissue
ut may derive from other structural lesions, including
yocardial edema and/or inflammation (21,22). Another
xplanation (11) can be an erroneous interpretation of the
yperintense signal because of the huge interobserver vari-
bility in the evaluation of the MRI findings. Therefore,
ardiac MRI can be misleading if used as an elective tool for
he morphologic analysis of myocardial tissue in patients
ith RV arrhythmias.
RVD and RV myocarditis. Patchy inflammatory infil-
rates were detected in four of nine patients with ARVD
44%), raising the possibility of an infectious/inflammatory
tiology of the disease. According to this theory, ARVD
ight result of a primary myocarditis, being the disappear-
nce of the RV myocardium as the consequence of an
nflammatory necrotic injury followed by a fibrofatty repair
23). This hypothesis, based on the frequent detection of
nflammatory infiltrates in patients with ARVD is, however,
ot universally accepted, because the inflammation could be
secondary event not implicated in the pathogenesis of the
isease. In other terms, an already diseased myocardium can
ave an increased susceptibility to viral infection (24) with
esulting myocardial inflammation that can eventually play a
ole in the clinical manifestations of the disease, increasing
he risk of arrhythmias (25,26).
Anyway, this was not the case in 70% of our patients in
hich myocarditis, incorporating various amounts of inter-
titial and replacement fibrosis thus suggesting a reparative
hase, was detected in the absence of fatty replacement.
oreover, inflammatory infiltrates were not found in LV
MB in any of the patients with ARVD, but in 48% of
atients with myocarditis. Viruses, the most commonly
stablished causal agents of myocarditis, were not found in
ny of the patients with ARVD, but were detected in 19%
f patients with histologic diagnosis of myocarditis, this
nding being at variance with Bowles et al. (24) who
etected virus sequences in 58% of patients with sporadic
RVD. The relatively low percentage of viral genome
etection may be related to the long-time interval between
iral infection and time to biopsy, being the presence of
eplacement fibrosis at histology, suggestive of a chronic
hase of the myocardial inflammation.
Finally, during follow-up, none of the patients with
yocarditis showed a detectable morphologic and arrhyth-
ogenic progression of the disease.
In conclusion, we believe that our patients were affected
y two different diseases: 30% by an ARVD and 70% by a
redominantly right-sided myocarditis simulating the clin-
cal and instrumental characteristics of an ARVD, as already
escribed in several case reports (27–29).
It is known that myocarditis in its clinical spectrum may
resent with even severe ventricular arrhythmias. The myo-
ardial inflammation can involve selectively the RV (30)
iving rise to RV electric instability and structural or
unctional abnormalities involving selectively the right side
f the heart. The significance of inflammatory infiltrates inRVD remains a controversial issue that still waits for a
onclusive explanation.
linical implications. Over 50% of cases of ARVD are
poradic (31). In the absence of a family history, patients
ith clinical and instrumental diagnosis of ARVD may well
e affected by a myocarditis involving predominantly the
V. These two conditions have often different prognosis
nd treatment. The former is a progressive entity where
ajor clinical intervention, as ICD implantation, or heart
ransplantation may be required, while the latter is often a
elf-limited process responding usually to a conservative
pproach.
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